{"count": 7, "results": [{"_id": "34779790", "pmid": 34779790, "title": "Is Metformin Use Associated with Prolonged Overall Survival in Patients with Soft Tissue Sarcoma? A SEER-Medicare Study.", "journal": "Clin Orthop Relat Res", "authors": ["Hutchinson ID", "Ata A", "DiCaprio MR"], "date": "2022-04-01T00:00:00Z", "doi": "10.1097/CORR.0000000000002045", "meta_date_publication": "2022 Apr 1", "meta_volume": "480", "meta_issue": "4", "meta_pages": "735-744", "score": 50258.832, "text_hl": "Is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use Associated with Prolonged Overall Survival in @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Sarcoma</m> @DISEASE_MESH:D012509 @@@Soft Tissue Sarcoma@@@? ", "citations": {"NLM": "Hutchinson ID, Ata A, DiCaprio MR. Is Metformin Use Associated with Prolonged Overall Survival in Patients with Soft Tissue Sarcoma? A SEER-Medicare Study. Clin Orthop Relat Res. 2022 Apr 1;480(4):735-744. PMID: 34779790", "BibTeX": "@article{34779790, title={Is Metformin Use Associated with Prolonged Overall Survival in Patients with Soft Tissue Sarcoma? A SEER-Medicare Study.}, author={Hutchinson ID and Ata A and DiCaprio MR}, journal={Clin Orthop Relat Res}, volume={480}, number={4}, pages={735-744}}"}}, {"_id": "34962495", "pmid": 34962495, "title": "CORR Insights : Is Metformin Use Associated with Prolonged Overall Survival In Patients with Soft Tissue Sarcoma? A SEER-Medicare Study.", "journal": "Clin Orthop Relat Res", "authors": ["Mayerson JL"], "date": "2022-04-01T00:00:00Z", "doi": "10.1097/CORR.0000000000002091", "meta_date_publication": "2022 Apr 1", "meta_volume": "480", "meta_issue": "4", "meta_pages": "745-747", "score": 50255.74, "text_hl": "CORR Insights : Is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use Associated with Prolonged Overall Survival In @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Sarcoma</m> @DISEASE_MESH:D012509 @@@Soft Tissue Sarcoma@@@? ", "citations": {"NLM": "Mayerson JL. CORR Insights : Is Metformin Use Associated with Prolonged Overall Survival In Patients with Soft Tissue Sarcoma? A SEER-Medicare Study. Clin Orthop Relat Res. 2022 Apr 1;480(4):745-747. PMID: 34962495", "BibTeX": "@article{34962495, title={CORR Insights : Is Metformin Use Associated with Prolonged Overall Survival In Patients with Soft Tissue Sarcoma? A SEER-Medicare Study.}, author={Mayerson JL}, journal={Clin Orthop Relat Res}, volume={480}, number={4}, pages={745-747}}"}}, {"_id": "24391834", "pmid": 24391834, "pmcid": "PMC3877110", "title": "Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug", "journal": "PLoS One", "authors": ["Garofalo C", "Capristo M", "Manara MC", "Mancarella C", "Landuzzi L", "Belfiore A", "Lollini PL", "Picci P", "Scotlandi K"], "date": "2013-12-31T00:00:00Z", "doi": "10.1371/journal.pone.0083832", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "12", "meta_pages": "e83832", "score": 50062.254, "text_hl": " In vitro sensitivity of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Sarcoma</m> @DISEASE_MESH:D012509 @@@sarcomas@@@.", "citations": {"NLM": "Garofalo C, Capristo M, Manara MC, Mancarella C, Landuzzi L, Belfiore A, Lollini PL, Picci P, Scotlandi K. Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug PLoS One. 2013;8(12):e83832. PMID: 24391834", "BibTeX": "@article{24391834, title={Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug}, author={Garofalo C and Capristo M and Manara MC and Mancarella C and Landuzzi L and Belfiore A and Lollini PL and Picci P and Scotlandi K}, journal={PLoS One}, volume={8}, number={12}, pages={e83832}}"}}, {"_id": "28319830", "pmid": 28319830, "title": "Anti-proliferative effect of metformin on a feline injection site sarcoma cell line independent of Mtor inhibition.", "journal": "Res Vet Sci", "authors": ["Pierro J", "Saba C", "McLean K", "Williams R", "Karpuzoglu E", "Prater R", "Hoover K", "Gogal R"], "date": "2017-10-01T00:00:00Z", "doi": "10.1016/j.rvsc.2017.03.003", "meta_date_publication": "2017 Oct", "meta_volume": "114", "meta_issue": "", "meta_pages": "74-79", "score": 50057.5, "text_hl": "Anti-proliferative effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on a feline injection site @<m>DISEASE_Sarcoma</m> @DISEASE_MESH:D012509 @@@sarcoma@@@ cell line independent of @GENE_MTOR @GENE_2475 @@@Mtor@@@ inhibition.", "citations": {"NLM": "Pierro J, Saba C, McLean K, Williams R, Karpuzoglu E, Prater R, Hoover K, Gogal R. Anti-proliferative effect of metformin on a feline injection site sarcoma cell line independent of Mtor inhibition. Res Vet Sci. 2017 Oct;114():74-79. PMID: 28319830", "BibTeX": "@article{28319830, title={Anti-proliferative effect of metformin on a feline injection site sarcoma cell line independent of Mtor inhibition.}, author={Pierro J and Saba C and McLean K and Williams R and Karpuzoglu E and Prater R and Hoover K and Gogal R}, journal={Res Vet Sci}, volume={114}, pages={74-79}}"}}, {"_id": "21356574", "pmid": 21356574, "title": "Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.", "journal": "Cancer Lett", "authors": ["Nilsson S", "Huelsenbeck J", "Fritz G"], "date": "2011-05-01T00:00:00Z", "doi": "10.1016/j.canlet.2010.12.022", "meta_date_publication": "2011 May 1", "meta_volume": "304", "meta_issue": "1", "meta_pages": "60-9", "score": 50054.906, "text_hl": "We found that @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@Lov@@@, @CHEMICAL_Diphosphonates @CHEMICAL_MESH:D004164 @@@BP@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ modulated the anticancer drug sensitivity of @<m>DISEASE_Sarcoma</m> @DISEASE_MESH:D012509 @@@sarcoma@@@ cells in an agent-, dose and time-dependent fashion. ", "citations": {"NLM": "Nilsson S, Huelsenbeck J, Fritz G. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells. Cancer Lett. 2011 May 1;304(1):60-9. PMID: 21356574", "BibTeX": "@article{21356574, title={Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.}, author={Nilsson S and Huelsenbeck J and Fritz G}, journal={Cancer Lett}, volume={304}, number={1}, pages={60-9}}"}}, {"_id": "29243803", "pmid": 29243803, "title": "Effect of metformin on fibrosarcoma in hamsters.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Popović DJ", "Lalošević D", "Miljković D", "Popović KJ", "Čapo I", "Popović JK"], "date": "2017-12-01T00:00:00Z", "doi": "10.26355/eurrev_201712_13941", "meta_date_publication": "2017 Dec", "meta_volume": "21", "meta_issue": "23", "meta_pages": "5499-5505", "score": 50052.777, "text_hl": "CONCLUSIONS: Administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ drug might be an effective and safe therapeutic approach in novel non-toxic therapies for @SPECIES_9606 @@@human@@@ @<m>DISEASE_Sarcoma</m> @DISEASE_MESH:D012509 @@@sarcomas@@@.", "citations": {"NLM": "Popović DJ, Lalošević D, Miljković D, Popović KJ, Čapo I, Popović JK. Effect of metformin on fibrosarcoma in hamsters. Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5499-5505. PMID: 29243803", "BibTeX": "@article{29243803, title={Effect of metformin on fibrosarcoma in hamsters.}, author={Popović DJ and Lalošević D and Miljković D and Popović KJ and Čapo I and Popović JK}, journal={Eur Rev Med Pharmacol Sci}, volume={21}, number={23}, pages={5499-5505}}"}}, {"_id": "24553119", "pmid": 24553119, "title": "Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.", "journal": "Cell Cycle", "authors": ["Issaq SH", "Teicher BA", "Monks A"], "date": "2014-01-01T00:00:00Z", "doi": "10.4161/cc.28010", "meta_date_publication": "2014", "meta_volume": "13", "meta_issue": "7", "meta_pages": "1152-61", "score": 50048.676, "text_hl": "Using @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2-deoxy-D-glucose@@@ (@CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2-DG@@@), a competitive inhibitor of glycolysis, @CHEMICAL_Oligomycins @CHEMICAL_MESH:D009840 @@@oligomycin@@@, an inhibitor of mitochondrial ATP synthase, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a widely used anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ drug and inhibitor of complex I of the mitochondrial respiratory chain, we evaluated the effects of metabolic inhibition on @<m>DISEASE_Sarcoma</m> @DISEASE_MESH:D012509 @@@sarcoma@@@ cell growth and bioenergetic function. ", "citations": {"NLM": "Issaq SH, Teicher BA, Monks A. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors. Cell Cycle. 2014;13(7):1152-61. PMID: 24553119", "BibTeX": "@article{24553119, title={Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.}, author={Issaq SH and Teicher BA and Monks A}, journal={Cell Cycle}, volume={13}, number={7}, pages={1152-61}}"}}]}